Carlos Nueno - 29 Nov 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
President, International
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
29 Nov 2024
Net transactions value
-$60,948
Form type
4
Filing time
03 Dec 2024, 17:30:08 UTC
Previous filing
27 Sep 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +1,056 1,056 29 Nov 2024 Direct F1
transaction TDOC Common Stock Options Exercise +1,123 +106% 2,179 29 Nov 2024 Direct F2
transaction TDOC Common Stock Options Exercise +3,100 +142% 5,279 29 Nov 2024 Direct F2
transaction TDOC Common Stock Sale $28,494 -2,389 -45% $11.93 2,890 02 Dec 2024 Direct F3
transaction TDOC Common Stock Sale $32,455 -2,890 -100% $11.23 0 03 Dec 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Options Exercise $0 -1,056 -17% $0.000000 5,285 29 Nov 2024 Common Stock 1,056 Direct F1, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -1,123 -50% $0.000000 1,123 29 Nov 2024 Common Stock 1,123 Direct F2, F6
transaction TDOC Restricted Stock Units Options Exercise $0 -3,100 -17% $0.000000 15,502 29 Nov 2024 Common Stock 3,100 Direct F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 6, 2023.
F5 On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On March 1, 2022, the reporting person was granted 13,475 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F7 On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.